Nanocarrier Based Topical Drug Delivery- A Promising Strategy for Treatment of Skin Cancer

Author:

Jain Rupesh1ORCID,Sarode Ila1ORCID,Singhvi Gautam1ORCID,Dubey Sunil Kumar1ORCID

Affiliation:

1. Department of Pharmacy, Birla Institute of Technology and Science, Pilani (BITS-PILANI), Pilani Campus, Rajasthan, India

Abstract

Skin cancers are one of the most widespread and complex forms of the disease, resulting in very high mortality rates across the world. The current treatments available for skin cancer include chemotherapy, surgery, radiotherapy, etc. The selected treatment options for skin cancer are usually decided based on the condition of a patient and the type of skin cancer. The effectiveness of skin cancer therapy is still limited because of poor penetrability of the drug into stratum corneum or lesions, low efficacy, required higher concentration of the active pharmaceutical ingredients to reach a therapeutic effect. Besides, low bioavailability at the site of action, the requirement of high dose, causes skin irritation, which significantly hinders the drug absorption through the stratum corneum. Thus, nanocarriers have been used to bypass the problems associated with conventional anti-cancer drug delivery systems. In the current scenario, nanotechnology-based therapy has shown great potential in the management of skin cancer, and these can be used for a more efficient drug delivery system to treat cancers. In this review article, the information on different nanocarrier systems for skin cancer has been elucidated. Moreover, the various nanoparticulate strategies and their effectiveness to treat skin cancer have been discussed.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Reference92 articles.

1. Brown M.B.; Martin G.P.; Jones S.A.; Akomeah F.K.; Dermal and transdermal drug delivery systems: current and future prospects. Drug Deliv 2006,13(3),175-187

2. Singh Malik D.; Mital N.; Kaur G.; Topical drug delivery systems: A patent review. In: Expert Opinion on Therapeutic Patents. Taylor and Francis Ltd 2016,26,213-8

3. Gupta M.; Agrawal U.; Vyas S.P.; Nanocarrier-based topical drug delivery for the treatment of skin diseases. Expert Opin Drug Deliv 2012,9(7),783-804

4. Das P.; Deshmukh N.; Badore N.; Ghulaxe C.; Patel P.; A Review Article on Melanoma. J Pharm Sci 2016,8(2),112-117

5. Smith V.; Walton S.; Treatment of facial basal cell carcinoma : A review. J Skin Cancer 2011,2011

Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3